Abstract
Background Despite broad interest in the health implications of sleep duration, traditional measurements via polysomnography or actigraphy are often limited to one or a few nights per person. Given the potential variability of sleep duration over time, inferential uncertainty remains an important issue for relatively short observation windows.
Methods We describe potential limitations of shorter duration sleep tracking by sub-sampling from longer-term observation windows, using a combined approach of simulated data from known distributions, in addition to real-world data (30-365 nights) from over 35,000 participants who provided informed consent to participate in the Apple Heart and Movement Study and elected to contribute sleep data to the study.
Results Simulations demonstrate that the magnitude of deviation from truth, defined using all available observations per individual, as well as the presence and direction of bias, depended on the sub-sample size, the type of simulated distribution (Gaussian versus skewed), and the summary statistics of interest, such as central tendency (mean, median) and dispersion (standard deviation (SD), interquartile range). For example, the SD computed from n=7 observations from a simulated normal distribution (7+1 hours) showed a median 6.7% under-estimation bias (IQR 24% under- to 14.7% over-estimation). Real-world sleep duration data, when under-sampled and compared to longer observations within-participant, showed similar SD bias at 7 nights, and similar convergence rates approaching the true value (based on 90 nights) as longitdunal sample number increases. Shapiro-Wilk tests for normality and log-normality show that 64% of simulated log-normal (skew) distributions fail to reject normality at n=7 samples, while real-world sleep duration data most commonly failed both normality and log-normality tests. Finally, simulated cohorts with sleep durations of 7+1 hours mixed with a subset of 6+1 hours sleepers showed that a random single-night observation of “short sleep” (6 hours) is more likely from random variation of a 7-hour sleeper, than from an actual 6-hour sleeper. Extending the observation to n=7 nights mitigates this mis-classification risk.
Conclusion The results of simulations and empiric data patterns suggests that longer duration tracking provides important and tangible benefits to reduce bias and uncertainty in sleep health research that historically relies on small observation windows.
Competing Interest Statement
The authors are employees of Apple, Inc.
Funding Statement
The Apple Heart & Movement Study receives funding from Apple, Inc. and the American Heart Association.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The parent study, Apple Heart and Movement Study (AHMS), was approved by the Advarra Central Institutional Review Board, and registered to ClinicalTrials.gov (ClinicalTrials.gov Identifier: NCT04198194).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The aggregated data that support the findings of this study can be made available on request from the corresponding author (M.B.). Request for data will be evaluated and responded to in a manner consistent with the specific language in the study protocol and informed consent form.
